Telmisartan, its potential therapeutic implications in cardiometabolic disorders.

Recent patents on cardiovascular drug discovery

Volumn 1, Issue 1, 2006, Pages 79-83

  Yamagishi, Sho ichi ^a   Nakamura, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; IMMUNOGLOBULIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TELMISARTAN; UNCLASSIFIED DRUG;

ANIMAL; CARDIOVASCULAR DISEASE; DIABETIC RETINOPATHY; DRUG EFFECT; HUMAN; INSULIN RESISTANCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; CARDIOVASCULAR DISEASES; DIABETIC RETINOPATHY; HUMANS; INSULIN RESISTANCE; PPAR GAMMA; RECEPTORS, IMMUNOLOGIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 34547830473     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489006775244281     Document Type: Review

References (74)